SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hui Wang, Souhayla El Maadidi, Janett Fischer, Elena Grabski, Sabine Dickhöfer, Sascha Klimosch, Sinead M. Flannery, Angela Filomena, Olaf-Oliver Wolz, Nicole Schneiderhan-Marra, Markus W. Löffler, Manfred Wiese, Tica Pichulik, Beat Müllhaupt, David Semela, Jean-François Dufour, Pierre-Yves Bochud, Andrew G. Bowie, Ulrich Kalinke, Thomas Berg, Alexander N.R. Weber, A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance, Hepatology, 2015, 62, 5
  2. 2
    Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar, Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-αBased Therapy, Mediators of Inflammation, 2015, 2015, 1

    CrossRef

  3. 3
    Mahdi Dehghan-Manshadi, Hossein Hadinedoushan, Mohammad Kazem Amirbaigy, Fateme Zare, Gilda Eslami, Seyyed Ali Mirghanizade-Bafghi, Mohsen Akhondi-Meybodi, Relative Expression of Toll-Like Receptors 2 and 7 mRNA in Peripheral Blood of Patients With Hepatitis C, Hepatitis Monthly, 2015, 15, 11

    CrossRef

  4. 4
    Nermin Abdel Hamid Sadik, Olfat Gamil Shaker, Hassan Zaki Ghanem, Heba Akram Hassan, Abdel-Hamid Zaki Abdel-Hamid, Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients, Archives of Virology, 2015, 160, 9, 2181

    CrossRef

  5. 5
    Edward J. Gane, Young-Suk Lim, Stuart C. Gordon, Kumar Visvanathan, Eric Sicard, Richard N. Fedorak, Stuart Roberts, Benedetta Massetto, Zhishen Ye, Stefan Pflanz, Kimberly L. Garrison, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Shyamasundaran Kottilil, Bradley Freilich, Carla S. Coffin, Wendy Cheng, Yoon Jun Kim, The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection, Journal of Hepatology, 2015, 63, 2, 320

    CrossRef

  6. 6
    Cheng Qian, Juan Liu, Xuetao Cao, Innate signaling in the inflammatory immune disorders, Cytokine & Growth Factor Reviews, 2014, 25, 6, 731

    CrossRef

  7. 7
    Reneé C. Ireton, Michael Gale, Pushing to a cure by harnessing innate immunity against hepatitis C virus, Antiviral Research, 2014, 108, 156

    CrossRef

  8. 8
    Nelson C. Di Paolo, Recognition of Human Oncogenic Viruses by Host Pattern-Recognition Receptors, Frontiers in Immunology, 2014, 5,

    CrossRef

  9. 9
    Ming Yue, Le Feng, Shai-di Tang, Jia-jia Wang, Xing-xin Xue, Wei-liang Ding, Yun Zhang, Xiao-zhao Deng, Sex-specific association between X-linked Toll-like receptor 7 with the outcomes of hepatitis C virus infection, Gene, 2014, 548, 2, 244

    CrossRef

  10. 10
    Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Fahad Al-Zoghaibi, Ayman A. Abdo, Faisal M. Sanai, Mohammed Q. Khan, Ali Albenmousa, Hamad I. Al-Ashgar, Mohammed N. Al-Ahdal, The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients, BioMed Research International, 2014, 2014, 1

    CrossRef

  11. 11
    Ming Yue, Chun-fang Gao, Jia-jia Wang, Chang-jun Wang, Le Feng, Jie Wang, Rong-bin Yu, Zhi-hang Peng, Xing-xin Xue, Li Cai, Nai-jun Fan, Yun Zhang, Xiao-zhao Deng, Toll-like receptor 7 variations are associated with the susceptibility to HCV infection among Chinese females, Infection, Genetics and Evolution, 2014, 27, 264

    CrossRef

  12. 12
    Veerle Bieghs, Christian Trautwein, The innate immune response during liver inflammation and metabolic disease, Trends in Immunology, 2013, 34, 9, 446

    CrossRef